Related references
Note: Only part of the references are listed.Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology
Anurag Bhalla et al.
ALLERGY (2021)
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
Andrea Matucci et al.
ALLERGY (2021)
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
Marco Caminati et al.
RESPIRATORY MEDICINE (2021)
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
Marco Caminati et al.
VACCINES (2021)
EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
Johannes W. J. Bijlsma
ANNALS OF THE RHEUMATIC DISEASES (2021)
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
John M. Kelso
VACCINE (2021)
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system
Emily Jane Woo et al.
VACCINE (2021)
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
Paul J. Turner et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2021)
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland
Piotr Rzymski et al.
VACCINES (2021)
The impact of COVID-19 on patients with asthma
Jose Luis Izquierdo et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Yong Jun Choi et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
COVID-19, asthma, and biological therapies: What we need to know
Mario Morais-Almeida et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2020)
Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial
Pamela L. Zeitlin et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)